Financial Times’ Europe’s Leading Start-up Hubs 2024 Announces DigitalHealth.London as the top UK Accelerator for Track-record

DigitalHealth.London has been recognised in the Financial Times inaugural ‘Europe’s Leading Start-up Hubs 2024’ ranking as the UK’s top accelerator programme for track-record.

Europe’s Leading Start-Up Hubs 2024 is an inaugural ranking by the Financial Times identifying the top centres for founders seeking to build or expand their companies through incubator and/or accelerator programs. In collaboration with Statista R (a subsidiary of the international data and research company Statista) and Sifted (a leading media brand for the European startup community), a total of 125 start-up hubs were recognised in the ranking.

DigitalHealth.London clinched the top spot in the UK for its exceptional track record, securing the 17th position out of 26 in the UK and Europe combined, and ranking 62nd among the total 125 start-up hubs across Europe. Track-record, as defined in the ranking, covers the aggregated and evaluated data from each start-up hub regarding the performance of the top five startups that engaged in their programmes.

To identify the leading hubs, a thorough registration and survey process was conducted in three phases:

1. Start-up hubs application phase
2. Alumni evaluation phase
3. Survey and data evaluation and analysis

Several evaluation factors were considered, focusing on alumni feedback from those who participated in each start-up hub’s incubator or accelerator programmes. Recommendations from external experts including investors (business angels, venture capital representatives), entrepreneurs, and academics were also taken into account, as well as the general performance of the most successful startups emerging from each hub.

To view the rankings, please visit Europe Leading Start-up Hubs (ft.com).

To find out more about the DigitalHealth.London flagship Accelerator programme, please visit Accelerator – DigitalHealth.London.

The DigitalHealth.London Accelerator programme is funded by the UK Government via the UK Shared Prosperity Fund (UKSPF). It is delivered by the Health Innovation Network (HIN) South London in partnership with the Office of Life Sciences, CW+, Medicity, NHS England, the Mayor of London and the Levelling Up Fund.

For more information, please visit https://www.gov.uk/government/publications/uk-
shared-prosperity-fund-prospectus.